Recruiting A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers NCT06805617 Conditions Adenocarcinoma, Adenoid Cystic Carcinoma, Advanced Salivary Gland Carcinoma, +14 more Locations Brigham and Women's Hospital — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
